Programmed cell death ligand 1 as a biomarker in head and neck cancer
The evaluation of programmed cell death ligand 1 has a potential role in the application of immune checkpoint inhibitors for select cancers of the head and neck. See related commentary on pages 000‐000.
Source: Cancer Cytopathology - Category: Pathology Authors: Sara I. Pai, William C. Faquin Tags: Commentary Source Type: research